Guardant Health, Inc. 8-K Filing: Key Events Update – January 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

1. Document Type: The report is an 8-K filing, which is used to disclose significant events that shareholders should know about.
2. Company Information:

• Name: Guardant Health, Inc.
• State of Incorporation: Delaware (DE)
• CIK Number: 0001576280
• SEC File Number: 001-38683
• EIN: 45-4139254
• Address: 3100 Hanover Street, Palo Alto, CA 94304
• Phone Number: 855-698-8887

3. Stock Information:

• Common Stock Par Value: $0.00001 per share
• Ticker Symbol: GH
• Exchange: NASDAQ

4. Filing Date: The report is dated January 13, 2025.
5. Duration Context: The context for this filing is a specific date—January 13, 2025, suggesting that the information pertains to events or conditions as of that date.
6. XBRL Information: The document is filed in XBRL format, which is used for the electronic submission of financial statements.

Insights:

• As an 8-K filing, this report likely contains information about a significant event affecting Guardant Health, which could include changes in management, mergers, acquisitions, financial restatements, or other material developments.
• The company is publicly traded on NASDAQ, indicating it is subject to SEC regulations and reporting requirements.
• The low par value of the common stock suggests that the company may be in a growth phase or is focused on retaining capital for reinvestment rather than distributing it to shareholders as dividends.

This information would be pertinent for investors, analysts, and stakeholders interested in understanding recent developments concerning Guardant Health, Inc.